期刊
PEDIATRICS
卷 118, 期 3, 页码 1215-1219出版社
AMER ACAD PEDIATRICS
DOI: 10.1542/peds.2006-0942
关键词
ADHD; attention deficit/hyperactivity disorder; stimulant; methylphenidate; amphetamine; sudden death; cardiovascular; blood pressure; pulse; electrophysiology
类别
资金
- NIDA NIH HHS [K24 DA016264] Funding Source: Medline
- NATIONAL INSTITUTE ON DRUG ABUSE [K24DA016264] Funding Source: NIH RePORTER
OBJECTIVE. Recently, a US Food and Drug Administration advisory committee raised concerns about cardiovascular risks and sudden death in children and adolescents with attention-deficit/hyperactivity disorder who are receiving stimulants. METHODS. We comment on the risk of sudden death in children/adolescents taking stimulants compared with population rates, biological plausibility, and known cardiovascular effects of stimulants to determine specific risk. RESULTS. There does not seem to be higher risk of sudden death in stimulant-treated individuals compared with the general population. Although there is evidence of biological plausibility, the known effects of the stimulants on cardiovascular electrophysiology and vital signs seem to be benign. CONCLUSIONS. There does not seem to be compelling findings of a medication-specific risk necessitating changes in our stimulant treatment of children and adolescents with attention-deficit/hyperactivity disorder. The use of existing guidelines on the use of stimulants (and psychotropic agents) may identify children, adolescents, and adults who are vulnerable to sudden death.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据